Patient Chart Audit Reveals Changing Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Dynamics As New Competition Challenges Alexion/Astra Zeneca's Soliris and Ultomiris
21. November 2024 09:27 ET
|
Spherix Global Insights
EXTON, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights has released its first annual chart audit study in hematology, Patient Chart Dynamix™ : Paroxysmal Nocturnal Hemoglobinuria (PNH)...
[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
21. November 2024 01:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Apheresis Equipment Market Size, Trends and Insights By Product Type...
IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
05. November 2024 09:00 ET
|
IN8bio, Inc
IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
Ichnos Glenmark Innovation (IGI) Announces First Presentation of Data from Phase 1 Study of the Trispecific ISB 2001 in Relapsed/Refractory Multiple Myeloma (r/rMM) at Upcoming ASH Annual Meeting
05. November 2024 09:00 ET
|
Ichnos Glenmark Innovation
IGI Announces First Presentation of Data from Phase 1 Study of the Trispecific ISB 2001 in Relapsed/Refractory Multiple Myeloma at ASH
Neutropenia Treatment Market to hit USD 20.8 billion by 2032, says Global Market Insights Inc.
04. November 2024 02:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Neutropenia Treatment Market size is projected to be worth USD 20.8 billion by the end of 2032. The increasing prevalence of cancer...
Hemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights
14. Oktober 2024 12:33 ET
|
Spherix Global Insights
EXTON, PA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Hemophilia, a genetic disorder that impairs blood clotting, affects thousands of people worldwide. The treatment landscape is rapidly evolving, fueled by...
Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
25. September 2024 08:16 ET
|
Spherix Global Insights
EXTON, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm, is expanding its specialized offerings to buy-side financial firms...
Apheresis Market Size to Surge to USD 6.7 Billion by 2034, Driven by Strong Growth Momentum at 7.7% CAGR | Report by Transparency Market Research, Inc.
28. August 2024 18:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 28, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global apheresis market...
Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising Advances in Gene Therapies
28. August 2024 10:14 ET
|
Spherix Global Insights
EXTON, PA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Despite advancements in treatments, sickle cell disease and thalassemia continue to present significant challenges for patients and healthcare providers....
US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold Agglutinin Disease
24. Juli 2024 14:00 ET
|
Spherix Global Insights
EXTON, PA, July 24, 2024 (GLOBE NEWSWIRE) -- Autoimmune hemolytic anemia (AIHA) encompasses a group of rare disorders characterized by the destruction of red blood cells due to autoantibodies. Among...